The influence of anxiety and depression on outcomes of patients with coronary artery disease

Archives of Internal Medicine

Volumn 160, Issue 13, 2000, Pages 1913-1921

  Januzzi Jr , James L ^b   Stern, Theodore A ^b   Pasternak, Richard C ^b   DeSanctis, Roman W ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGER; ANGINA PECTORIS; ANXIETY; CORONARY ARTERY DISEASE; CORONARY RISK; DEPRESSION; HEART DEATH; HEART PALPITATION; HUMAN; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH;

EID: 0034631985     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.13.1913     Document Type: Review

References (132)

1. Williams JC. Practical Observations on Nervous and Sympathetic Palpitations of the Heart. London, England: Longman Rees Orme Browne; 1836.
2. Osler W. The Lumleian lectures on angina pectoris. Lancet. 1892;1:829-844.
3. Menninger K, Menninger W. Psychoanalytic observations in cardiac disorders. Am Heart J. 1936; 11:10-21.
4. Dunbar HF. Coronary occlusion: dynamic formulation. In: Dunbar HF, ed. Psychosomatic Disorders. New York, NY: Paul B Hoebner; 1943; 307-320.
5. Wolf S. Psychosocial forces in myocardial infarction and sudden death. Circulation. 1969;40 (suppl IV):IV74-IV83.
6. Kawachi I, Sparrow D, Spiro A III, Vokonas P, Weiss ST. A prospective study of anger and coronary heart disease: the Normative Age Study. Circulation. 1996;94:2090-2095.
7. Williams RB. Psychological factors in coronary artery disease: epidemiological evidence. Circulation. 1987;76(suppl 1):1117-1123.
8. Mittleman MA, Maclure M, Sherwood JB, et al. Triggering of acute myocardial infarction onset by episodes of anger. Circulation. 1995;92:1720-1725.
9. Blazer DG, Keller RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry. 1994;151:979-986.
10. Orth-Gomer K, Johnson JV. Social network interaction and mortality: a six year follow-up of a random sample of the Swedish population. J Chronic Dis. 1987;4:944-957.
11. Frasure-Smith N, Prince R. Long-term follow-up of the Ischemic Heart Disease Life Stress Monitoring Program. Psychosom Med. 1989; 51:485-513.
12. Frasure-Smith N. In-hospital symptoms of psychological stress as predictors of long-term outcome after acute myocardial infarction in men. Am J Cardiol. 1991;67:121-127.
13. Frasure-Smith N, Lesperance F, Juneau M. Differential long-term impact of in-hospital symptoms of psychological stress after non-Q-wave acute myocardial infarction. Am J Cardiol. 1992; 69:1128-1134.
14. Kubzansky LD, Kawachi I, Spiro A III, Weiss ST, Vokonas PS, Sparrow D. Is worrying bad for your heart? a prospective study of worry and coronary heart disease in the Normative Aging Study. Circulation. 1997;95:818-824.
15. Haines AP, Imeson JD, Meade TW. Phobic anxiety and ischaemic heart disease. BMJ. 1987; 295:297-299.
16. Sullivan M, LaCroix A, Baum C, Grothous MA, Katon W. Functional status in coronary artery disease: a one-year prospective study of the role of anxiety and depression. Am J Med. 1997;103: 348-356.
17. Kawachi I, Colditz GA, Ascerio A, et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation. 1994;89: 1992-1997.
18. Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease: the Normative Aging Study. Circulation. 1994;90:2225-2229.
19. Barefoot JC, Helms MJ, Mark DB, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol. 1996;78: 613-617.
20. Lesperance F, Frasure-Smith N, Theroux P. Depression influences 1-year prognosis in unstable angina. J Am Coll Cardiol. 1998;31:208(a).
21. Wells K, Rogers W, Burnam M, Camp P. Course of depression in patients with hypertension, myocardial infarction or insulin dependent diabetes. Am J Psychiatry. 1993;150:632-638.
22. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA. 1993;270: 1819-1825.
23. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 1995;91:999-1005.
24. Friedman M, Rosenman RH. Association of specific overt behavior pattern with blood and cardiovascular findings: blood cholesterol level, blood clotting time, incidence of arcusenills, and clinical coronary artery disease. JAMA. 1959; 169:1286-1296.
25. Denollet J, Sys S, Stoobant N, Rombouts H, Gillebert T, Brutsaert D. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet. 1996; 347:417-421.
26. Friedman HS. Where is the disease-prone personality? In: Friedman HS, ed. Personality and Disease. New York, NY: John Wiley & Sons Inc; 1990:283-292.
27. Denollet J, Brutsaert D. Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation. 1998;97: 167-173.
28. Rosenman RH, Brand RJ, Jenkins CD, Friedman M, Straus R, Wurm M. Coronary heart disease in the Western Collaborative Group Study: final follow-up experience of 8.5 years. JAMA. 1975;233:872-877.
29. Haynes SG, Feinleib M, Kannel WB. The relationship of psychosocial factors to coronary heart disease in the Framingham Study, III: eight-year incidence of coronary heart disease. Am J Epidemiol. 1980;111:37-43.
30. Blumenthal JA, Williams RB, Kong Y, Schanberg SM, Thompson LW. Type A behavior pattern and angiographic findings. JAMA. 1978; 240:761-763.
31. Shekelle RB, Hulley SB, Neaton JD, et al. The MR-FIT behavior pattern study, II: type A behavior and the incidence of coronary heart disease. Am J Epidemiol. 1985;122:559-570.
32. Barefoot JC, Peterson BL, Harrell FE, et al. Type -A behavior and survival: a follow up study of 1,467 patients with coronary artery disease. Am J Cardiol. 1989;64:427-432.
33. Ragland DR, Brand RJ. Type A behavior and mortality from coronary heart disease. N Engl J Med. 1988;318:65-69.
34. Coryell W, Noyes R, House JD. Mortality among outpatients with anxiety disorders. Am J Psychiatry. 1986;143:508-510.
35. Weissman MM, Markowitz JS, Ouellette R, Greenwald S, Kahn J. Panic disorders and cardiovascular/cerebrovascular problems: results from a community survey. Am J Psychiatry. 1990;147:1504-1508.
36. Anda R, Williamson D, Jones D, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology. 1993;4:285-294.
37. Aromaa A, Raitasalo R, Reunanen A, et al. Depression and cardiovascular diseases. Acta Psychiatr Scand Suppl. 1994;377:77-82.
38. Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction. Circulation. 1996;94:3123-3129.
39. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction and total mortality in a community sample. Circulation. 1996; 93:1976-1980.
40. Ford DE, Mead LA, Chang PF, Cooper-Patrick L, Wang N-Y, Klag MJ. Depression is a risk factor for coronary artery disease in men: the Precursors Study. Arch Intern Med. 1998;158:1422-1426.
41. Crown S, Crisp AH. A short clinical diagnostic self-rating scale for psychoneurotic patients: the Middlesex Hospital questionnaire. Br J Psychiatry. 1956;112:917-923.
42. Zyzanski SJ, Jenkins CD, Ryan TJ, Flessas A, Everist M. Psychological correlates of coronary angiographic findings. Arch Intern Med. 1976; 136:1234-1237.
43. Crowe J, Runions J, Ebbesen L, Oldridge N, Streiner D. Anxiety and depression after acute myocardial infarction. Heart Lung. 1996;25:98-107.
44. Carney RM, Freedland K, Sheline Y, Weiss E. Depression and coronary heart disease: a review for cardiologists. Clin Cardiol. 1997;20:196-200.
45. Moser DK, Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med. 1996;58:395-401.
46. Cassem NH, Hackett TP. Psychiatric consultation in a coronary care unit. Ann Intern Med. 1971;75:9-14.
47. Stern TA, Caplan RA, Cassem NH. Use of benzodiazepines in a coronary care unit. Psychosomatics. 1987;28:19-22.
48. Frasure-Smith N, Lesperance F, Talajic M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol. 1995;14:388-398.
49. Thomas SA, Friedmann E, Wimbuh F, Schron E. Psychosocial factors and survival in the Cardiac Arrhythmia Suppression Trial (CAST): a reexamination. Am J Crit Care. 1997;6:116-126.
50. Herrmann C, Brand-Driehorst S, Kaminsky B, Leibing E, Staats H, Ruger U. Diagnosis groups and depressed mood as predictors of 22-month mortality in medical patients. Psychosom Med. 1998;60:570-577.
51. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1995.
52. Fava M, Abraham M, Pava J, Shuster J, Rosenbaum J. Cardiovascular risk factors in depression: the role ot anxiety and anger. Psychosomatics. 1996;37:31-37.
53. Esler M, Turbott J, Scharz R. et al. The peripheral kinetics of norepinephrine in depressive illness. Arch Gen Psychiatry. 1982;39:285-300.
54. Watkins LL, Grossman P, Krishnan R, Sherwood A. Anxiety and vagal control of heart risk. Psychosom Med. 1998;50:498-502.
55. Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Decreased heart rate variability in men with phobic anxiety (data from the Normative Aging Study). Am J Cardiol. 1995;75:882-885.
56. van Boven AJ, Jukema JW, Haaksma J, Zwinderman AH, Crijns HJ, Lie KI, for the REGRESS Study Group. Depressed heart rate variability is associated with events in patients with stable coronary artery disease and preserved left ventricular function. Am Heart J. 1998;135:571-576.
57. Frasure-Smith N, Lesperance F, Prince R, etal. Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet. 1997;350:473-479.
58. Yeung A, Vekshtein V, Krantz D, et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med. 1991;325:1551-1556.
59. Manuck S, Olsson G, Hjemdahl P, Rehnqvist N. Does cardiovascular reactivity to mental stress have prognostic value in postinfarction patients? a pilot study. Psychosom Med. 1992;54: 102-108.
60. Krantz D, Helmers K, Bairey CN, Nebel L, Hedges S, Rozanski A. Cardiovascular reactivity and mental stress-induced myocardial ischemia in patients with coronary artery disease. Psychosom Med. 1991;53:1-12.
61. Dakak N, Quyyumi A, Eisenhofer G, Goldstein DS, Cannon RO. Sympathetically mediated effects of mental stress on the cardiac microcirculation of patients with coronary artery disease. Am J Cardiol. 1995;76:125-130.
62. Levine SP, Towell BL, Saurez AM, Khierriem LK, Harris MM, George JN. Platelet activation and secretion associated with emotional stress. Circulation. 1985;71:1129-1134.
63. Raikkonen K, Lassila R, Keltikanga-Jarvinen L, Hautanen A. Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men. Arterioscler Thromb Vasc Biol. 1996;16:363-367.
64. Carney RM, Freedland KE, Rich MW, Jaffe AS. Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms. Ann Behav Med. 1995; 17:142-149.
65. Glassman AH, Helzer JE, Covey LS, et al. Smoking, smoking cessation, and major depression. JAMA. 1990;264:1546-1549.
66. Glassman AH. Cigarette smoking: implications for psychiatric illness. Am J Psychiatry. 1993; 150:546-553.
67. Carney RM, Rich MW, Freedland KE, et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med. 1988;50:627-633.
68. Frasure-Smith N, Lesperance F, Juneau M, Talajic M, Bourassa MG. Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med. 1999;61:26-37.
69. Blazer DG. Social support and mortality in an elderly community population. Am J Epidemiol. 1982;115:684-694.
70. Wells KB, Burnam MA, Rogers W, Hays R, Camp P. The course of depression in adult outpatients: results from the Medical Outcomes Study. Arch Gen Psychiatry. 1992;49:788-794.
71. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA. 1989;262:914-919.
72. Lloyd GG, Cawley RH. Distress or illness? a study of psychosocial symptoms after myocardial infarction. Br J Psychiatry. 1983;142:120-125.
73. Schleifer SJ, Macari MM, Slater W, Kahn M, Zucker H, Gorlin R. Predictors of outcome after myocardial infarction: role of depression. Circulation. 1974;2:2-10.
74. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, treatment. Am J Psychiatry. 1998;55:580-592.
75. Follick MJ, Ahern DK, Gorkin L, et al. Relation of psychosocial and stress reactivity variables to ventricular arrhythmias in the Cardiac Arrhythmia Pilot Study. Am J Cardiol. 1990; 66:63-67.
76. Carney RM, Freedland KE, Rich MW, Smith LJ, Jaffe AS. Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. Am J Med. 1993;95:23-28.
77. Ladwig KH, Kieser M, Konig J, Breithardt G, Borggrefe M. Affective disorders and survival after myocardial infarction: results from the Post-Infarction Late Potential Study. Eur Heart J. 1991; 12:959-964.
78. Rosenman RH, Brand RJ, Sholtz RI, Friedman M. Multivariate prediction of coronary heart disease during 8.5 year followup of the Western Collaborative Group Study. Am J Cardiol. 1976;37: 903-910.
79. Rechlin T, Weis M, Aspitzer A, Kaschka H. Are affective disorders associated with alterations of heart rate variability? J Affect Disord. 1994;32: 271-275.
80. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol. 1995;76:562-564.
81. Watkins LL, Grossman P. Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am Heart J. 1999;137:453-457.
82. Hjemdahl P, Larrson PT, Wallen NH. Effects of stress and beta-blockade on platelet function. Circulation. 1991;84(suppl 6):VI44-VI61.
83. Schwartz PJ, Snebold NG, Brown AM. Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol. 1976;37:1034-1040.
84. Kliks RB, Burgess MJ, Abildskov JA. Influence of sympathetic tone on ventricular fibrillation threshold during experimental coronary occlusion. Am J Cardiol. 1975;36:45-49.
85. Podrid PJ, Fuchs T, Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation. 1990;82(suppl 1):I103-I110.
86. Otto MW, Reilly-Harrington NA, Harrington JA. Cognitive-behavioral therapy. In: Stern TA, Herman JB, Flavin PL, eds. The MGH Guide to Psychiatry in Primary Care. New York, NY: McGraw-Hill: 1998:543-547.
87. Williams RB, Littman AB. Psychosocial factors: role in cardiac risk and treatment strategies. Cardiol Clin. 1996;14:97-104.
88. Brennan A, Efficacy of cardiac rehabilitation 2: smoking and behaviour modification. Br J Nurs. 1997;6:737-740.
89. Blumenthal JA, Wei J. Psychobehavioral treatment in cardiac rehabilitation. Cardiol Clin. 1993; 11:323-331.
90. Oldenburg B, Martin A, Greenwood J, Bernstein L, Allan R. A controlled trial of a behavioral and educational intervention following coronary artery bypass surgery. J Cardiopulm Rehabil. 1995; 15:39-46.
91. Bennett P, Carroll D. Cognitive-behavioral interventions in cardiac rehabilitation. J Psychosom Res. 1994;38:169-182.
92. Black JL, Allison TG, Williams DE, Rummans TA, Gau GT. Effect of intervention for psychological distress on rehospitalization rates in cardiac rehabilitation patients. Psychosomatics. 1998;39: 134-143.
93. Dafoe W, Huston P. Current trends in cardiac rehabilitation. CMAJ. 1997;156:527-532.
94. Linden W, Stossel CC, Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med. 1996; 156:745-752.
95. Schneiderman N. Enhancing Recovery in Coronary Heart Disease (ENRICHD) Patients. Bethesda, Md: National Heart, Lung, and Blood Institute; 1994. Publication NHLBI-HC-94-28.
96. Blumenthal JA, Jiang W, Babyak MA, et al. Stress management and exercise training in cardiac patients with myocardial ischemia: effects on prognosis and evaluation of mechanisms. Arch Intern Med. 1997;157:2213-2223.
97. Cossette S, Frasure-Smith N, Lesperance F. Impact of improving psychological distress in post-MI patients [abstract]. Presented at: American Psychosomatic Society Meeting; March 18, 1999; Vancouver, British Columbia.
98. Tesar GE. Cardiovascular side effects of psychotropic agents. In: Stern TA, Herman JB, Flavin PL, eds. The MGH Guide to Psychiatry in Primary Care. New York, NY: McGraw-Hill; 1998: 505-517.
99. Boyer W, Chernow B, Lake CR. Psychopharmacology in the intensive care unit. Psychiatr Clin North Am. 1984;7:901-907.
100. Glassman AH. The newer antidepressant drugs and their cardiovascular effects. Psychoparmacol Bull. 1984;20:272-279.
101. Sheline YI, Freedland KE, Carney RM. How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease? Am J Med. 1997;102:54-59.
102. Warrington SJ, Padgham C, Lader M. The cardiovascular effects of antidepressants. Psychol Med Monogr Suppl. 1989;16:i-iii, 1-40.
103. Stern TA. The management of depression and anxiety following myocardial infarction. Mt Sinai J Med. 1985;52:623-633.
104. Hurt RD, Sachs DPL, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1998; 337:1195-1202.
105. Roose SP, Dalack GW, Slassman AH, Woodring S, Walsh BT, Giardina EG. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry. 1991;148:512-516.
106. Askinazi C. SSRI treatment of depression with comorbid cardiac disease. Am J Psychiatry. 1996; 153:135-136.
107. Roose SP, Glassman AH, Attia E, Woodring S, Giardina EG, Bigger JT Jr. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry. 1998;155:660-665.
108. Roose SP, Laghrissi-Thode F, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA. 1998;279:287-291.
109. Sigal SL, Gellman J, Anderson GM, et al. Potentiation of the vasospastic response to angioplasty by pretreatment with fluoxetine. Arterioscler Thromb. 1993;13:907-914.
110. Markovitz JH, Shuster J, Tolbert L. Effects of sertraline treatment of depression on platelet activation in an open-label study: implications for coronary disease [abstract]. Presented at: American Psychosomatic Society Meeting; March 18, 1999; Vancouver, British Columbia.
111. Sertraline Antidepressant Heart Randomized Trial (SADHART). New York, NY: Pfizer Inc; 1997.
112. Welch CA, Drop LJ. Cardiovascular effects of ECT. Convuls Ther. 1989;5:35-43.
113. Dec GW Jr, Stern TA, Welch CP. The effects of electroconvulsive therapy on serial electrocardiograms and serum cardiac enzyme values: a prospective study of depressed hospitalized inpatients. JAMA. 1985;253:2525-2529.
114. McKenna G, Engle RP, Brooks H, Dalen J. Cardiac arrhythmias during electroshock therapy: significance, prevention, and treatment. Am J Psychiatry. 1970;127:530-533.
115. Zielinski RJ, Roose SP, Devanand DP, Woodring S, Sackeim HA. Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry. 1993;150:904-909.
116. Larsen JR, Hein L, Stromgren LS. Ventricular tachycardia with ECT. JECT. 1998;14:109-114.
117. McCall WV. Asystole in electroconvulsive therapy: report of four cases. J Clin Psychiatry. 1996;57: 199-203.
118. Ring BS, Parnass SM, Shulman RB, Phelan J, Khan SA. Cardiogenic shock after electroconvulsive therapy. Anesthesiology. 1996;84:1511-1513.
119. Ali PB, Tidmarsh MD. Cardiac rupture during electroconvulsive therapy. Anaesthesia. 1997;52: 884-886.
120. Chow T, DeSanctis RW. Myocardial stunning and infarction due to coronary artery spasm from electroconvulsive therapy. Cardiovasc Rev Rep. 1998;10:37-39.
121. Stoudemire A, Knos G, Gladson M, et al. Labetalol in the control of cardiovascular responses to electroconvulsive therapy in high-risk depressed medical patients. J Clin Psychiatry. 1990; 51:508-512.
122. Hedback B, Perk J, Wodlin P. Long-term reduction of cardiac mortality after myocardial infarction: 10-year results of a comprehensive rehabilitation programme. Eur Heart J. 1993;14:831-835.
123. Burgess AW, Lerner DJ, D'Agostino RB, Vokonas PS, Hartman CR, Gaccione P. A randomized control trial of cardiac rehabilitation. Soc Sci Med. 1987;24:359-370.
124. Milani RV, Lavie CJ, Cassidy MM. Effects of cardiac rehabilitation and exercise training programs on depression in patients after major coronary events. Am Heart J. 1996;132:726-732.
125. Mayou R. Rehabilitation after heart attack. BMJ. 1996;313:1515-1516.
126. Denollet J, Brutsaert DL. Enhancing emotional well-being by comprehensive rehabilitation in patients with coronary heart disease. Eur Heart J. 1995;16:1070-1078.
127. Oldridge MB, Guyatt GH, Fischer ME, Rimm AA. Cardiac rehabilitation after myocardial infarction: combined experience of randomized clinical trials. JAMA. 1988;260:945-950.
128. Lavie CJ, Milani RV. Effects of cardiac rehabilitation and exercise training programs in patients > or=75 years of age. Am J Cardiol. 1996; 78:675-677.
129. Lavie CJ, Milani RV. Benefits of cardiac rehabilitation and exercise training in elderly women. Am J Cardiol. 1997;79:664-666.
130. Milani RV, Lavie CJ. Behavioral differences and effects of cardiac rehabilitation in diabetic patients following cardiac events. Am J Med. 1996; 100:517-523.
131. Jones DA, West RR. Psychological rehabilitation after myocardial infarction: multicentre randomised controlled trial. BMJ. 1996;313:1517-1521.
132. Wenger NK, Froelicher ES, Smith LK, et al. Cardiac Rehabilitation, Clinical Guideline No. 17. Bethesda, Md: Agency for Health Care Policy and Research, National Heart, Lung, and Blood Institute, Public Health Service, Dept of Health and Human Services; October 1995. Publication AHCPR 96-0672.